- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
October 13th, 2005
Charles Q. Choi: Analysts are studying last week's acquisition by Invitrogen of Quantum Dot Corp., the nanotech startup that laid claim to all key life-science applications for quantum dots, trying to guess the sale amount and what it might mean for the industry.
Some nanotechnologists consider the sale of the Hayward, Calif., company a success, seeing it as a corporate leader's validation of the company as worthy of investment. Others are not so sure.
United Press International
|Related News Press|
Artificial synapse rivals biological ones in energy consumption June 21st, 2016
Nanometrics Announces Upcoming Investor Events May 10th, 2016